tiprankstipranks
National Research Corp (NRC)
NASDAQ:NRC
US Market
Want to see NRC full AI Analyst Report?

National Research (NRC) Earnings Dates, Call Summary & Reports

228 Followers

Earnings Data

Report Date
Apr 28, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
0.25
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 03, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized meaningful progress across leading indicators (TRCV +8%, new sales +86%, highest retention in 7+ years), strong profitability (29% adjusted EBITDA margin) and clear product/organizational momentum (Rounding TRCV nearly doubled, AI initiatives, strategic hires). The primary negatives were a 4% full-year revenue decline and lingering impacts from elevated TRCV attrition in H2 2024 that created tough comps and pressured 2025 revenue. Management framed the revenue weakness as largely cyclical and expectant of recovery in 2026 as TRCV converts to recognized revenue. Overall, positive operational and financial fundamentals outweigh the near-term revenue drag.
Company Guidance
Management's guidance emphasized that revenue growth should resume in 2026 driven by TRCV, which rose 8% year‑over‑year to $144.1M (up 2% sequential) and is 99% recurring after five consecutive quarters of sequential TRCV growth; they cited go‑to‑market changes (full‑year new sales +86% YoY), Rounding TRCV nearly doubling in 2025, cross‑sell/enablement adoption, AI enhancements, retention upside (highest gross dollar retention in >7 years) and new‑logo opportunities as key catalysts. Financially, they pointed to FY2025 revenue of $137.4M (down 4% YoY) with adjusted EBITDA $40.2M (29% margin) and Q4 revenue $35.2M (down 5% YoY, +2% sequential), Q4 adjusted EBITDA $8.7M, adjusted EPS $0.93 for the year ($0.16 in Q4), durable free cash flow, and a $0.12 quarterly dividend—expecting margin expansion as revenue recovers and capital allocation via reinvestment, dividends, opportunistic buybacks and strategic M&A.
TRCV Growth and Predictability
Total recurring contract value (TRCV) reached $144.1M, up 8% year-over-year and 2% sequentially, marking the fifth consecutive quarter of sequential TRCV growth; 99% of revenue is recurring, reinforcing revenue visibility and predictability.
New Sales Acceleration
Full-year new sales increased 86% year-over-year following a sales team reorganization and refined coverage model that drove larger, more strategic relationships.
Improved Retention and Customer Satisfaction
Achieved the highest gross dollar retention rate in more than 7 years and a Net Promoter Score of 68; served 74% of the top 100 U.S. health systems, reflecting strong customer trust and engagement.
Rounding and Enablement Momentum
Rounding (workflow-driven enablement solution) saw TRCV nearly double in 2025, signaling strong adoption of enablement solutions and meaningful cross-sell opportunities across customers.
Strong Profitability and Margin Discipline
Full-year adjusted EBITDA was $40.2M with a 29% margin; Q4 adjusted EBITDA was $8.7M. Adjusted net income for the year was $20.7M with adjusted EPS of $0.93, and Q4 adjusted EPS was $0.16, demonstrating maintained profitability despite revenue headwinds.
Product Innovation and AI Integration
Investments in product innovation and AI (comment summarization, AI-enabled service recovery, AI-powered listening beta for Rounding) aimed at improving insight-to-action velocity and expanding addressable market.
Leadership and Strategic Hires
Senior hire of David Burik to lead strategic insights and governance strategy, strengthening expertise in governance, system transformation and accelerating growth of Market Insights and Governance Institute offerings.
Capital Allocation and Cash Returns
Demonstrated free cash flow durability and a disciplined approach to capital allocation: returned capital via a $0.12 per share quarterly dividend and signaled opportunistic share repurchases while retaining flexibility for strategic M&A.

National Research (NRC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NRC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 28, 2026
2026 (Q1)
- / -
0.252
Feb 03, 2026
2025 (Q4)
- / 0.08
0.281-72.60% (-0.20)
Oct 27, 2025
2025 (Q3)
- / 0.18
0.24-25.00% (-0.06)
Jul 28, 2025
2025 (Q2)
- / >-0.01
0.258-103.10% (-0.27)
Apr 28, 2025
2025 (Q1)
- / 0.25
0.265-4.91% (-0.01)
Jan 27, 2025
2024 (Q4)
- / 0.28
0.36-21.94% (-0.08)
Oct 25, 2024
2024 (Q3)
- / 0.24
0.32-25.00% (-0.08)
Aug 06, 2024
2024 (Q2)
- / 0.26
0.29-11.03% (-0.03)
May 07, 2024
2024 (Q1)
- / 0.27
0.281-5.69% (-0.02)
Feb 13, 2024
2023 (Q4)
- / 0.36
0.26834.33% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NRC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 03, 2026
$21.70$17.46-19.54%
Oct 27, 2025
$11.22$13.02+16.03%
Jul 28, 2025
$13.57$12.91-4.84%
Apr 28, 2025
$10.48$11.47+9.50%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does National Research Corp (NRC) report earnings?
National Research Corp (NRC) is schdueled to report earning on Apr 28, 2026, After Close (Confirmed).
    What is National Research Corp (NRC) earnings time?
    National Research Corp (NRC) earnings time is at Apr 28, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NRC EPS forecast?
          Currently, no data Available